Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 23, 1998

View Archived Issues

Oxford BioMedica, RPR In £11 million Deal

Mologen, Virbac Enter Agreement For Vaccines

Australian Food Industry Assails Labeling Decision

British Biotech Drops One Marimastat Study

Early Progen Study Finds Enzyme Blocker Effective

Antisoma Raises £10M, Achieves Market Listing

Australia's Biotech Market Lacks Depth, Analysts Say

Xenova Plans Phase II Study Of Cancer Drug

Chiroscience Mulls Strategy For Anesthetic's Marketing

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...